Schulze-Bergkamen Henning, Krammer Peter H
Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany.
Semin Oncol. 2004 Feb;31(1):90-119. doi: 10.1053/j.seminoncol.2003.11.006.
Resistance towards apoptosis is a key factor for the survival of a malignant cell. Cancer results if there is too little apoptosis and cells grow faster and live longer than normal cells. In addition, defects in apoptosis signaling contribute to drug resistance of tumor cells. Thus, one of the main goals for oncologic treatment is to overcome resistance of tumor cells towards apoptosis. The exciting challenge in oncology is to translate the growing knowledge of apoptotic pathways into clinical applications. In this review we address the role of apoptosis signaling in tumorigenesis and drug resistance of tumor cells and discuss therapeutic approaches interfering with apoptosis pathways.
对细胞凋亡的抵抗是恶性细胞存活的关键因素。如果细胞凋亡过少,导致细胞生长速度比正常细胞更快且存活时间更长,就会引发癌症。此外,细胞凋亡信号传导缺陷会导致肿瘤细胞产生耐药性。因此,肿瘤治疗的主要目标之一是克服肿瘤细胞对细胞凋亡的抵抗。肿瘤学面临的一项令人兴奋的挑战是将对凋亡途径不断增加的认识转化为临床应用。在本综述中,我们阐述了细胞凋亡信号传导在肿瘤发生和肿瘤细胞耐药性中的作用,并讨论了干扰凋亡途径的治疗方法。